Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
IMVT
#1121
Immunovant, Inc. Common Stock
27.730
0
+3.28%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+3.28%
Aylık değişim
+3.47%
6 aylık değişim
+44.35%
Yıllık değişim
+44.35%
Önceki kapanış
26.850
0
Open
27.730
0
Bid
Ask
Low
27.730
0
High
27.730
0
Hacim
113
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
IMVT
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
169.86 M
170.92 M
174.32 M
175.28 M
203.53 M
—
Valuation ratios
Enterprise value
3.83 B
2.21 B
2.19 B
2.3 B
4.18 B
10.88 B
Price to earnings ratio
-9.53
-6.26
-5.63
-5.7
-9.49
-27.08
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-11.03
-6.89
-5.91
-5.98
-10.01
-28.79
Price to book ratio
1.81
3.66
1.17
1.18
1.51
7.52
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.14
0.18
0.22
0.11
0.64
Return on equity %
0.32
0.15
0.2
0.24
0.11
0.7
Return on invested capital %
-5 436.74
-5 278.94
-1 831.81
-1 051.21
-900.63
-9 062.58
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.04
11.16
12.32
9.07
15.74
48.29
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.68
0.73
0.69
0.59
0.51
2.52
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.55
4.71
3.5
3.01
5.48
16.7
Net current asset value per share
2.81
5.06
3.81
3.3
5.75
17.93
Tangible book value per share
2.4
4.67
3.56
2.99
5.43
16.65
Working capital per share
2.34
4.61
3.5
2.94
5.38
16.44
Book value per share
2.4
4.67
3.56
2.99
5.43
16.65
Haberler
Immunovant stock hits 52-week high at 28.32 USD
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Immunovant hisseleri 27,87 dolar ile tüm zamanların en yüksek seviyesine ulaştı
Immunovant stock hits all-time high at 27.87 USD
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Roivant Sciences 2025 4. Çeyrek: Olumlu brepocitinib verileri ilaç geliştirme ivmesini artırıyor
Immunovant hisseleri, 3. çeyrek zararı daralıp tahminleri aştıkça %7 yükseldi
Immunovant shares jump 7% as Q3 loss narrows, beats estimates
Philip Morris, Biogen, Telenor, and more set to report earnings Friday